INARI MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 38.42 USD | +0.92% |
|
-0.44% | -40.82% |
| 02/04 | Inari Medical, Inc. Appoints Tim Benner as Senior Vice President of U.S. Sales | CI |
| 01/04 | Inari Medical, Inc.(NasdaqGS:NARI) added to S&P 600 Health Care | CI |
Chart calendar Inari Medical, Inc.
5694bf07557ba191.D9au8RvhAnhU_iVhdHyCEDsjWEMJMBXqmiIKQvdVIXs.RqzEtHTVek4hmU8vBk_uQHRmNTN9cniT9lZhOJIKTglJu_SYYaJnMSapFQ~517f955464627af120dabb2c178c8ad2
Upcoming events on Inari Medical, Inc.
Past events on Inari Medical, Inc.
| 25/04/2024 01:30 am | Annual General Meeting |
| 29/02/2024 03:00 am | Q4 2023 Earnings Call |
| 29/02/2024 02:35 am | Q4 2023 Earnings Release |
| 10/01/2024 11:15 pm | JPMorgan Healthcare Conference |
| 30/11/2023 02:30 am | Piper Sandler Healthcare Conference |
| 15/11/2023 04:30 pm | Jefferies London Healthcare Conference |
| 02/11/2023 02:00 am | Q3 2023 Earnings Call |
| 02/11/2023 01:31 am | Q3 2023 Earnings Release |
| 12/09/2023 09:45 pm | Baird Global Healthcare Conference |
| 11/09/2023 08:10 pm | Morgan Stanley Global Healthcare Conference |
| 08/09/2023 06:15 pm | Wells Fargo Healthcare Conference |
| 10/08/2023 01:30 am | Canaccord Genuity Growth Conference |
| 03/08/2023 02:00 am | Q2 2023 Earnings Call |
| 03/08/2023 01:31 am | Q2 2023 Earnings Release |
| 08/06/2023 04:30 am | Venous Symposium |
| 18/05/2023 08:30 pm | Annual General Meeting |
| 10/05/2023 03:30 am | Bank of America Healthcare Conference |
| 04/05/2023 02:00 am | Q1 2023 Earnings Call |
| 04/05/2023 01:31 am | Q1 2023 Earnings Release |
| 06/04/2023 09:30 pm | Wells Fargo Medtech Innovation Spotlight Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 51,1 | 140 133 5.38% | 277 272 1.76% | 383 383 0.09% | 494 494 -0.01% | 588 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 19,8 16,3 21.83% | 15,3 12,6 21.35% | -21,0 -27,3 23.09% | 8,36 0,57 1356.18% | -24,0 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 18,4 11,5 60.47% | 10,8 10,7 1.24% | -28,1 -31,8 11.57% | -2,37 -7,68 69.11% | -39,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 13,8 6,93 98.98% | 10,7 9,95 7.42% | -26,2 -30,6 14.48% | 4,25 6,72 -36.8% | -38,5 |
|
Net income Million USD | Released Forecast Spread | 0,00 | 13,8 5,70 141.9% | 9,84 7,86 25.19% | -29,3 -32,5 9.99% | -1,64 2,38 -168.76% | -30,7 |
|
EPS USD | Released Forecast Spread | -0,14 | 0,27 0,11 140% | 0,18 0,18 -1.37% | -0,55 -0,62 10.88% | -0,03 0,05 -158.7% | -0,53 |
| Announcement Date | 21/02/20 | 09/03/21 | 23/02/22 | 27/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 83,2 79,8 4.33% | 86,8 83,6 3.76% | 92,7 87,8 5.63% | 96,2 90,8 5.92% | 108 106 1.77% | 116 110 5.32% | 119 117 1.95% | 126 122 3.61% | 132 132 0.01% | 138 | 140 | 150 | 159 | 163 |
|
EBITDA Million USD | Released Forecast Spread | 3,44 0,19 1761.62% | -1,98 -5,17 61.64% | -8,10 -12,6 35.83% | -8,02 -12,5 35.79% | -4,00 -8,59 53.45% | -2,37 -11,8 79.89% | 0,63 -8,10 107.77% | 4,29 -1,74 345.92% | 3,13 -1,99 257.37% | -8,61 | -7,75 | -3,97 | 0,43 | 16,0 |
|
EBIT Million USD | Released Forecast Spread | 1,75 1,33 31.45% | -3,08 -5,46 43.55% | -9,33 -12,4 24.64% | -9,80 -13,7 28.65% | -5,89 -9,48 37.84% | -5,34 -13,3 59.83% | -1,51 -10,3 85.38% | 2,11 -3,26 164.84% | -0,32 -3,46 90.77% | -14,0 | -12,7 | -8,86 | -4,27 | 0,25 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,68 1,11 51.54% | -3,13 -5,83 46.36% | -8,94 -12,1 26% | -9,31 -14,3 35.04% | -4,81 -9,24 47.95% | -1,19 -12,1 90.11% | 3,02 -7,01 143.14% | 5,59 0,73 665.58% | -3,18 -0,71 -345.35% | -13,9 | -12,0 | -8,65 | -3,13 | 1,80 |
|
Net income Million USD | Released Forecast Spread | 1,11 1,11 -0.2% | -3,13 -5,64 44.55% | -10,2 -12,2 16.3% | -10,2 -13,9 26.79% | -5,80 -9,09 36.25% | -2,22 -12,6 82.37% | 2,09 -6,86 130.42% | 3,16 0,33 846.68% | -4,67 -0,65 -614.61% | -11,0 | -10,3 | -6,21 | -1,69 | 1,80 |
|
EPS USD | Released Forecast Spread | 0,02 0,02 0% | -0,06 -0,10 41.46% | -0,19 -0,23 18.1% | -0,19 -0,25 24.75% | -0,11 -0,17 35.83% | -0,04 -0,23 82.93% | 0,04 -0,12 132.32% | 0,05 0,00 1065.5% | -0,08 -0,01 -540% | -0,19 | -0,19 | -0,12 | -0,04 | 0,03 |
| Announcement Date | 23/02/22 | 04/05/22 | 03/08/22 | 02/11/22 | 27/02/23 | 03/05/23 | 02/08/23 | 01/11/23 | 28/02/24 | - | - | - | - | - |
| 29/04/2024 | SHENZHEN YHLO BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
Past sector events for Inari Medical, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NARI Stock
- Calendar Inari Medical, Inc.
